Related Experiment Video

Updated: May 11, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

PEP-1-CAT protects hypoxia/reoxygenation-induced cardiomyocyte apoptosis through multiple sigaling pathways

Lei Zhang1, Shuang Wei, Jun-Ming Tang

  • 1Institute of Clinical Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China.

Journal of Translational Medicine
|May 7, 2013
PubMed
Abstract

Insights

PEP-1-CAT fusion protein protects cardiomyocytes from hypoxia/reoxygenation injury by entering cells and activating protective pathways. This novel approach enhances cell survival and reduces oxidative damage.

Area of Science:

  • Cardiovascular Biology
  • Cellular Stress Response
  • Biotechnology

Background:

  • Catalase (CAT) mitigates oxidative damage but struggles with cellular entry.
  • Hypoxia/reoxygenation (H/R) induces significant cardiomyocyte injury.
  • PEP-1-CAT fusion protein aims to overcome delivery limitations for enhanced cellular protection.

Purpose of the Study:

  • To investigate the protective effects of PEP-1-CAT fusion protein against H/R-induced injury in cardiomyocytes.
  • To elucidate the underlying molecular mechanisms of PEP-1-CAT-mediated cardioprotection.

Main Methods:

  • H9c2 cardiomyocytes were treated with CAT or PEP-1-CAT before H/R exposure.
  • Apoptosis, superoxide anion levels, and mitochondrial membrane potential were assessed.
  • Western blotting analyzed key apoptosis-related proteins and signaling pathways (MAPK, PI3K/Akt, Erk1/2).

Main Results:

  • PEP-1-CAT significantly reduced H/R-induced cell damage, LDH release, and malondialdehyde levels.
  • PEP-1-CAT inhibited apoptosis by modulating Bcl-2/Bax expression and preserving mitochondrial membrane potential.
  • PEP-1-CAT suppressed p38 MAPK while activating PI3K/Akt and Erk1/2 signaling pathways.

Conclusions:

  • PEP-1-CAT effectively protects cardiomyocytes from H/R injury.
  • The fusion protein acts by blocking the Bcl2/Bax/mitochondrial apoptotic pathway.
  • PEP-1-CAT activates PI3K/Akt and Erk1/2 signaling, offering a novel cardioprotective strategy.

Related Concept Videos

Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...